Back to MW MARSHALL WACE, LLP
EPRX3 quarters
Position history for MWMARSHALL WACE, LLP's holdings in EUPRAXIA PHARMACEUTICALS INC
MARSHALL WACE, LLP holds 158,133 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $1M as of 2026-Q2. EPRX represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$1M
Current Shares
158,133
Total Value Change
-$148,648
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.